Skip to product information
1 of 1


Human Apolipoprotein H/Apo H ELISA Kit Distributor

Human Apolipoprotein H/Apo H ELISA Kit Distributor


Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Human Apolipoprotein H/Apo H ELISA Kit Distributor



Cat Num


Product Name

Human Apolipoprotein H/Apo H ELISA Kit

Customs Name

Human Apolipoprotein H/Apo H ELISA Kit





Assay Type

Sandwich ELISA

Suitable Sample Type

serum, plasma, cell culture supernates


96-well strip plate


4℃ (unopened)standard stored at -20℃, others stored at 4℃ (opened)

Shipping Condition


Sample Volume

50 μl


16.18 pg/ml

Standard Curve Range

125 - 8000 pg/ml

Spike Recovery Range


Mean Spike Recovery


CV of Intra plate

2.4 % - 6.3 %

CV of Inter plate

3.9 % - 4.6 %


96-well polystyrene microplate coated with a monoclonal antibody against Apo H
Human Apo H Standard, lyophilized
Apo H Detect Antibody
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers


This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human Apo H. The Human Apolipoprotein H/Apo H ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Apolipoprotein H (Apo H), previously known as β2-glycoprotein I, is a multifunctional apolipoprotein that in humans is encoded by the APOH gene. It is a glycoprotein synthesized by liver cells. One of its functions is to bind cardiolipin. Apo H binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. Apo H has a complex involvement in agglutination, it appears to alter ADP mediated agglutination of platelets. It may prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. Normally Apo H assumes an anti-coagulation activity in serum (by inhibiting coagulation factors). Its plasma concentrations are strongly associated to metabolic syndrome alterations and vascular disease in type 2 diabetic and could be considered as a clinical marker of cardiovascular risk.